XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Compensation
6 Months Ended
Jun. 30, 2022
Share-Based Compensation  
Share-Based Compensation

10. Share-Based Compensation

Performance-Contingent Awards

The Company periodically grants performance-contingent share-based awards to employees. For the three and six months ended June 30, 2022, the Company recognized $0.1 million and $0.2 million, respectively, of share-based compensation expense related to these types of awards. As of June 30, 2022, there were 305,000 shares of performance-contingent restricted share units (“RSUs”) outstanding that have a maximum remaining share-based compensation expense of $2.5 million with performance expiration dates through December 2025. For the three and six months ended June 30, 2021, the Company recognized $0.1 million and $0.6 million, respectively, of share-based compensation expense related to performance-contingent share-based awards.

Share-Based Compensation Modification Due to Corporate Restructuring

As a result of the Company’s corporate restructuring announcement in September 2021 (see “Note 12. Corporate Restructuring Update”), the Board of Directors’ Compensation Committee approved the acceleration of certain equity awards for employees affected by the restructuring. The Company accounted for this acceleration as a Type III modification (improbable to probable) which resulted in a fair value of $2.5 million, as of the modification date, that was recorded in “Restructuring and related expenses” within the condensed consolidated statements of operations. The total cumulative compensation cost previously recognized for these awards of $0.8 million within “Research and development” and “Selling, general and administrative” through the modification date, was reversed. The acceleration resulted in net incremental share-

based compensation expenses of $0.4 million and $1.7 million for the three and six months ended June 30, 2022, respectively, and impacted approximately 45 terminated employees who met the conditions of the acceleration and departed the Company in the first half of 2022.